MAURICE COUGHLAN: Open Payments
NPI 1164710547 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $88
Food & beverage: $88
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Auvelity, FANAPT, CAPLYTA, ARISTADA, WAINUA.
Industry payments across MA — which companies pay providers there.
